Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300192
- Awardee
-
Pierce Biotechnology Inc. UEI CCSJMTEVB1V7 Part of Thermo Electron Corporation
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,608
Award facts
- Contract value 100% obligated
- $3,608.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Pierce Biotechnology Inc., a subsidiary of Thermo Electron Corporation, received a federal contract award on April 25, 2012, for the procurement of drugs and biologicals. This $3,608 firm fixed-price contract was executed as a Blanket Purchase Agreement (BPA) call without set-aside designation and is scheduled for completion by February 28, 2013. The funding agency is a civilian federal entity under the Office of the Director, with performance specified at the Bethesda, Maryland location (20892).
Thermo Electron Corporation's Financial Services Division, the parent entity, is an established supplier of scientific instruments and laboratory equipment to federal agencies. Pierce Biotechnology's role as the awardee reflects the parent company's broader portfolio serving agencies such as the Department of Health and Human Services in providing specialized research and diagnostic materials. The modest contract value and BPA call structure indicate this represents an individual task order placed under an existing indefinite delivery vehicle, consistent with the streamlined procurement approach utilized by federal agencies for routine acquisitions of laboratory supplies and biologicals.
Quick answers
Who was awarded contract HHSN26300192?
HHSN26300192 was awarded to Pierce Biotechnology Inc. by Office of the Director (National Institutes of Health) on April 25, 2012.
How much is contract HHSN26300192 worth?
The government has obligated $3,608 on HHSN26300192.
Is contract HHSN26300192 an order under another contract?
Yes. HHSN26300192 is a BPA call under HHSN263199800049380B, a blanket purchase agreement.
Was contract HHSN26300192 competed?
The extent of competition for HHSN26300192 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award